PATENT CLAIM ANALYSIS

Application Number: 15779929
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-12
Patent Classification: ["548", "435000"]

Abstract:
The present invention provides organic compounds which are capable of releasing carbon monoxide under physiological conditions or pH trigger, and to the use of such compounds for conditioning a cell, tissue or organ, for example, to protect against ischaemic injury during a transplant event.

Claim (Index 7):
The norbornenone compound of  claim 1 , wherein R 1 , R 2 , R 3  and R 4 , are each independently selected from C 1-6 alkyl and monocyclic aryl or hetaryl; wherein the alkyl, aryl and hetaryl group, are each optionally substituted with 1-3 substituents independently selected from halo, CN, NO 2 , OC(O)R 5 , C(O)R 5 , C(O)OR 5 , OR 5 , OS(O) 2 R 5 , NR 5 R 6 , SR 5 , polyethylene glycol, and mono-, di-, or tri-saccharide; and R 5  and R 6  are each independently selected from hydrogen, C 1-4 alkyl, and C 1-4 haloalkyl.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 93.0
- Lexical Diversity: 1.225
- Patent Class: 548.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['11311731', '11338587', '12643641', '10561153', '11785998']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7717611012483683
- 35 USC 102 Novelty (BERT): 0.5278631780211507
- Combined Prediction Score: 0.7473713089256465
- Mean Citation Score: 294.66267
- Max Citation Score: 354.02344
- Similarity Product: 261.59999189997194

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test